aggressive lymphoma

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
Jan 20, 2023

B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)

Recruiting
  • B Cell Lymphoma
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +9 more
  • NKX019
  • Denver, Colorado
  • +6 more
Jan 19, 2022

Aggressive Lymphoma Trial in Göttingen (Bendamustine and subcutaneous rituximab)

Completed
  • Aggressive Lymphoma
  • Bendamustine and subcutaneous rituximab
  • Göttingen, Germany
    Prof. Trümper
Dec 27, 2018

Aggressive Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma Trial in Spain (Rituximab, Gemcitabine, Oxaliplatin,

Completed
  • Aggressive Lymphoma
  • +2 more
  • Rituximab, Gemcitabine, Oxaliplatin, Dexametasone
  • Badalona, Barcelona, Spain
  • +27 more
Oct 27, 2017